NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/31/2026
Back to search
Official data from USPTO
CENTER FOR PHARMACOECONOMICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
CENTER FOR PHARMACOECONOMICS
ST13
US500000098876461Class
9, 35, 36, 41
Filing
98876461
Registration
8198440
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
03/31/2026
Trademark type
Word
Nice classes
9, 35, 36, 41
Filing date
11/27/2024
Registration date
03/31/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/31/2026
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
10/22/2024
First use in commerce
10/22/2024
Drawing code
4
Owner type
16
Owner location
Boston, MA, US
Examiner
EMILO, LORI ANNE
Law office
L80
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Leerink Intermediate Holdings LLC
Representatives
Cynthia J. Walden Fish & Richardson P.C.
Technical classification
Nice Classes
Class 9Class 35Class 36Class 41
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable reportselectronic newsletters and educational materials related to financial matters and business consulting in the biotechnologypharmaceuticalhealth fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology
Class 35
Business consulting; Business advisory; Business consultation servicesbusiness evaluation regarding firms in the biotechnologypharmaceuticalhealth fields for the assessment of the business value of medical and pharmaceutical innovation and technology
Class 36
Financial servicesnamely consulting and advising related to financial matters in the biotechnologypharmaceuticalhealth fields for the assessment of the financial value of medical and pharmaceutical innovation and technology; Providing information related to financial matters in the biotechnologypharmaceuticalhealth fields for the assessment of the financial value of medical and pharmaceutical innovation and technology
Class 41
providing a website featuring online non-downloadable content in the nature of instructional videosrelated to financial matters and business consulting in the biotechnologypharmaceuticalhealth fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring online non-downloadable instructional videoswebinars and podcasts related to financial matters and business consulting in the biotechnologypharmaceuticalhealth fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring online non-downloadable instructional videoswebinars and podcasts in the field of finance; Arranging and conducting conferences and events in the field of finance
Publications
History of USPTO decisions and trademark events.
30 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
03/31/2026
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
03/03/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/11/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
02/11/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
02/11/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
02/11/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
02/11/2026
GAUN
NOTIFICATION OF NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
02/10/2026
GAUD
NOTICE OF UNRESPONSIVE AMENDMENT - E-MAILED
02/10/2026
NAUD
REPORT UNRESPONSIVE AMENDMENT - COMPLETED
02/10/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/28/2026
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/28/2026
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
01/28/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/08/2026
GNFR
FINAL REFUSAL E-MAILED
01/08/2026
CNFR
FINAL REFUSAL WRITTEN
01/08/2026
IUAA
USE AMENDMENT ACCEPTED
01/08/2026
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
11/26/2025
IUAF
USE AMENDMENT FILED
11/26/2025
EAAU
TEAS AMENDMENT OF USE RECEIVED
11/26/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/26/2025
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
08/27/2025
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
08/27/2025
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
05/27/2025
GNRT
NON-FINAL ACTION E-MAILED
05/27/2025
CNRT
NON-FINAL ACTION WRITTEN
05/27/2025
DOCK
ASSIGNED TO EXAMINER
05/20/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/26/2025
NWAP
NEW APPLICATION ENTERED
11/27/2024
Continuous trademark protection
Get notified about every new filing that threatens CENTER FOR PHARMACOECONOMICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.